
    
      The goal of this study is to demonstrate the effectiveness of pentoxifylline compared to
      placebo in AAH while studying putative mechanisms that are plausible and testable. The main
      hypothesis is that pentoxifylline reduces the 90-day mortality of AAH.

      This study never moved forward due to funding issues.
    
  